Back to search

Article

Developing a SARS-CoV-2 Antigen Test Using Engineered Affinity Proteins

2021-04-19

Abstract excerpt

The ongoing COVID-19 pandemic has clearly established how vital rapid, widely accessible diagnostic tests are in controlling infectious diseases and how difficult and slow it is to scale existing technologies. Here, we demonstrate the use of the rapid affinity pair identification via directed selection (RAPIDS) method to discover multiple affinity pairs for SARS-CoV-2 nucleocapsid protein (N-protein), a biomarker...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
f7a13a89-0d9e-584e-b628-e494409c3be4
DOI
10.26434/chemrxiv.14442785.v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Developing a SARS-CoV-2 Antigen Test Using Engineered Affinity ProteinsDOI 10.26434/chemrxiv.14442785.v1
Select a neighboring publication to make it the new centre.